Thomsen Jillian B.

Chief Financial Officer | SVP &Chief Accounting Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+23.4%

Avg 12M Return

+77.3%

Thomsen Jillian B. is a Chief Financial Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $20.6M based on current market prices.

Holdings by Company

NKTRFeb 16, 2023

Current Shares313.5K

Value$20.60M

Net Activity-580,908

Bought: 0Sold: 580.9K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 16, 2023	NKTR Nektar Therapeutics	Chief Financial Officer	Sell	10,267	$3.00	$30,801.00	-3.2%	-76.5%	-76.1%
Nov 16, 2022	NKTR Nektar Therapeutics	Chief Financial Officer	Sell	11,095	$3.57	$39,609.15	-3.3%	-14.2%	-85.7%
Aug 16, 2022	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	2,006	$4.76	$9,548.56	-0.6%	-12.8%	-83.6%
May 16, 2022	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	5,841	$3.95	$23,071.95	-3.3%	+26.5%	-81.6%
Feb 16, 2022	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	2,363	$10.95	$25,874.85	-1.4%	-64.8%	-73.4%
Nov 16, 2021	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	6,741	$13.16	$88,711.56	-4.4%	-18.3%	-73.5%
Aug 16, 2021	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	13,339	$13.83	$184,478.37	-8.8%	-3.1%	-66.0%
May 17, 2021	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	13,391	$18.30	$245,055.30	-8.1%	-24.3%	-78.3%
Feb 16, 2021	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sell	11,705	$22.37	$261,840.85	-6.6%	-	-
Jan 28, 2021	NKTR Nektar Therapeutics	SVP &Chief Accounting Officer	Sale+OE	75,000	$18.62	$1,396,500.00	-29.8%	-	-